Market Cap 26.10M
Revenue (ttm) 140,000.00
Net Income (ttm) 9.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 6,478.57%
Debt to Equity Ratio 0.01
Volume 110,700
Avg Vol 176,388
Day's Range N/A - N/A
Shares Out 13.12M
Stochastic %K 57%
Beta 2.88
Analysts Strong Buy
Price Target N/A

Company Profile

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN...

Industry: Pharmaceutical Retailers
Sector: Healthcare
Phone: 800 261 0281
Address:
6308 Benjamin Rd, Suite 708, Tampa, United States
paideia
paideia Jul. 28 at 6:01 PM
$SCNX Even though Rezenopy is available only by prescription, aren't police, EMTs, Hospitals, fire departments all over the country going to prefer having it? How's that going to work?
0 · Reply
Li9999
Li9999 Jul. 28 at 1:55 PM
$SCNX I’m out since Mar 18 ,2023 , sorry everyone here
0 · Reply
stockinvestbull
stockinvestbull Jul. 28 at 8:55 AM
$SCNX It's rising nicely. There's still room to go up. 📈
0 · Reply
Supporter67
Supporter67 Jul. 26 at 3:30 PM
$SLS I‘m convinced they will need money. A financing is not a problem as long as you do it smart. Not like in the past. Look at $SCNX. They did a bridge financing last week. No toxic warrant. No sweetener at all. They sold shares directly to one institutional client. $SLS did very bad financings in the past. As if Anson or Highbridge would have something in the hand against Angelos. Like the Epstein filed.
1 · Reply
BinaryLogic
BinaryLogic Jul. 26 at 1:57 AM
2 · Reply
BinaryLogic
BinaryLogic Jul. 26 at 1:57 AM
$SCNX [Again] Liquidity remains the issue here, and the Company if on queue issues a very limited placement to specific investors (enumerated in the PR) for $1.2M with the possibility of scaling to $3.0M at a $1.59 strike. This is Bullish (IMO). The Liquidity issue is being addressed, there is limited impact to shareholders, the $1.59 strike is a marked premium from just 1mos ago, and this implies the Company does not require much stop-gap funding (hopefully) before administering NWC and debt organically (sales/FCF). The SP might retrace further to either the Bull flag support ($1.8) or investor ($1.6), and I will continue to DCA into the pull back. RSI cooling, pull-back to support awaiting Arbli sales and Rezenopy launch. Multiplier upside from this level (IMO), 6-12mos. https://www.stocktitan.net/news/SCNX/
2 · Reply
pAmdd
pAmdd Jul. 25 at 6:19 PM
$SCNX they don’t have money to start production and marketing of the drug 3 million is absolutely nothing they will run this company into the ground
1 · Reply
APEDM
APEDM Jul. 25 at 5:22 PM
$SCNX Many people sold at 1.9-2
0 · Reply
JackCampbell
JackCampbell Jul. 25 at 3:21 PM
$SCNX the way how they raise funds is excellent for us shareholders. Only if needed from time to time and in smallest tranches and hopefully much higher share prices each. Investors swoop up all new available shares instantly as they are very confident to multiple their investment here. Double digits soon!!!
1 · Reply
DW65
DW65 Jul. 25 at 2:15 PM
$SCNX perfect time to be bought up by one of the big dogs
2 · Reply
Latest News on SCNX
Scienture Holdings Announces Cancelation of ELOC

Jun 17, 2025, 8:05 AM EDT - 5 weeks ago

Scienture Holdings Announces Cancelation of ELOC


SCIENTURE Announces Executive Leadership Transition

May 22, 2025, 8:05 AM EDT - 2 months ago

SCIENTURE Announces Executive Leadership Transition


Scienture Holdings, Inc. Issues Annual Letter to Shareholders

Apr 3, 2025, 8:26 AM EDT - 4 months ago

Scienture Holdings, Inc. Issues Annual Letter to Shareholders


TRxADE Health, Inc. Announces Special Cash Dividend

Jul 9, 2024, 8:05 AM EDT - 1 year ago

TRxADE Health, Inc. Announces Special Cash Dividend


Trxade health, Inc files its 3Q 10Q

Jan 17, 2024, 9:07 AM EST - 1 year ago

Trxade health, Inc files its 3Q 10Q


TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing

Aug 14, 2023, 10:25 AM EDT - 2 years ago

TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing


TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Call Transcript

May 15, 2023, 10:30 PM EDT - 2 years ago

TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Call Transcript


TRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Call Transcript

Mar 27, 2023, 9:30 PM EDT - 2 years ago

TRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Call Transcript


paideia
paideia Jul. 28 at 6:01 PM
$SCNX Even though Rezenopy is available only by prescription, aren't police, EMTs, Hospitals, fire departments all over the country going to prefer having it? How's that going to work?
0 · Reply
Li9999
Li9999 Jul. 28 at 1:55 PM
$SCNX I’m out since Mar 18 ,2023 , sorry everyone here
0 · Reply
stockinvestbull
stockinvestbull Jul. 28 at 8:55 AM
$SCNX It's rising nicely. There's still room to go up. 📈
0 · Reply
Supporter67
Supporter67 Jul. 26 at 3:30 PM
$SLS I‘m convinced they will need money. A financing is not a problem as long as you do it smart. Not like in the past. Look at $SCNX. They did a bridge financing last week. No toxic warrant. No sweetener at all. They sold shares directly to one institutional client. $SLS did very bad financings in the past. As if Anson or Highbridge would have something in the hand against Angelos. Like the Epstein filed.
1 · Reply
BinaryLogic
BinaryLogic Jul. 26 at 1:57 AM
2 · Reply
BinaryLogic
BinaryLogic Jul. 26 at 1:57 AM
$SCNX [Again] Liquidity remains the issue here, and the Company if on queue issues a very limited placement to specific investors (enumerated in the PR) for $1.2M with the possibility of scaling to $3.0M at a $1.59 strike. This is Bullish (IMO). The Liquidity issue is being addressed, there is limited impact to shareholders, the $1.59 strike is a marked premium from just 1mos ago, and this implies the Company does not require much stop-gap funding (hopefully) before administering NWC and debt organically (sales/FCF). The SP might retrace further to either the Bull flag support ($1.8) or investor ($1.6), and I will continue to DCA into the pull back. RSI cooling, pull-back to support awaiting Arbli sales and Rezenopy launch. Multiplier upside from this level (IMO), 6-12mos. https://www.stocktitan.net/news/SCNX/
2 · Reply
pAmdd
pAmdd Jul. 25 at 6:19 PM
$SCNX they don’t have money to start production and marketing of the drug 3 million is absolutely nothing they will run this company into the ground
1 · Reply
APEDM
APEDM Jul. 25 at 5:22 PM
$SCNX Many people sold at 1.9-2
0 · Reply
JackCampbell
JackCampbell Jul. 25 at 3:21 PM
$SCNX the way how they raise funds is excellent for us shareholders. Only if needed from time to time and in smallest tranches and hopefully much higher share prices each. Investors swoop up all new available shares instantly as they are very confident to multiple their investment here. Double digits soon!!!
1 · Reply
DW65
DW65 Jul. 25 at 2:15 PM
$SCNX perfect time to be bought up by one of the big dogs
2 · Reply
TomMac64
TomMac64 Jul. 25 at 2:12 PM
$SCNX They are low in cash !
0 · Reply
APEDM
APEDM Jul. 25 at 2:02 PM
$SCNX Scienture Announces Manufacturing Launch Activities For Arbli Through Subsidiary Scienture, In Collaboration With Saptalis Pharmaceuticals And Strategic Distribution Partners, Targeting July 2025 Commercial Launch
0 · Reply
Li9999
Li9999 Jul. 25 at 11:37 AM
$SCNX SCN-102 (losartan oral suspension) – FDA-approved and launches expected in Q3 2025 under the brand name Arbli™
0 · Reply
APEDM
APEDM Jul. 25 at 7:17 AM
$SCNX https://www.sec.gov/Archives/edgar/data/1382574/000164117225020877/form8-k.htm https://www.sec.gov/Archives/edgar/data/1382574/000164117225020877/ex99-1.htm
0 · Reply
PoFolks_Capital
PoFolks_Capital Jul. 25 at 3:15 AM
$SCNX been here since march and since then the bearish talk was dilution from the eloc. Now they canceled the eloc which should signal they have other plans besides dilution. Everyone can keep looking for something negative to push but at this point it doesn't matter. Buyers have been pushing it up and that's all the bullish news you need to know right now.
0 · Reply
chubbypapa
chubbypapa Jul. 25 at 1:18 AM
$SCNX I entered on 1.9, and July is about to pass. Are they facing any difficulties?
0 · Reply
Trash_Man
Trash_Man Jul. 24 at 11:29 PM
$SCNX I was able to get partial fill at the 1.93 dip. Did anyone take advantage of the dip?
0 · Reply
FilingTracker
FilingTracker Jul. 24 at 9:24 PM
$SCNX Capital raise was at $1.59/share: https://www.sec.gov/Archives/edgar/data/1382574/000164117225020877/form8-k.htm
3 · Reply
AmoredBull24
AmoredBull24 Jul. 24 at 6:08 PM
$SCNX Slow and Steady , with the 3rd qtr of 2025 we should see more climb to 3+ imo
0 · Reply
AmoredBull24
AmoredBull24 Jul. 24 at 6:05 PM
$SCNX its up 100% in a month lol
1 · Reply
AmoredBull24
AmoredBull24 Jul. 24 at 6:02 PM
$SCNX lets go
0 · Reply
pAmdd
pAmdd Jul. 24 at 5:10 PM
$SCNX told you this one is dead money
0 · Reply